"Should RVX-208 improve eGRF, would this synergy be part and parcel of the existing RVX-208 patent, or would it need to be covered by a new patent?"
Great question. Alkaline phosphatase, eGFR, MACE benefit in CKD group and below median LDL-C, heart failure, cognition. I'm very excited to hear more tomorrow about results and patent(s). I'm not sure what all is covered or not in current parents.
BDAZ